Brand record
Dabur's ayurvedic products: what is on record
Last checked 10 October 2026
No Indian AYUSH action against Dabur is on record: Dabur Chyawanprash is not banned and Dabur was the plaintiff in the Delhi High Court case of 6 Nov 2025, while Hajmola and Fem bleach appear on the US FDA's unapproved-drug import alert (2024), a US border matter.
- Classification
- No ban or recall found in official records
- Decided by
- No Indian regulator action on record
- Reference
- Delhi High Court, Dabur India v Patanjali Ayurved, 6 Nov 2025; US FDA Import Alert 66-41 (India list updated 9 Oct 2026)
- Latest action
- 6 November 2025
- Last checked
- 10 October 2026
Photo: An Ayurvedic Pharmacy, Rishikesh (1).jpg by Ken Wieland from Philadelphia, USA (CC BY-SA 2.0). All photo credits.
US FDA Import Alert 66-41: unapproved drugs
Scope. A record here does not by itself mean a product or company is unsafe or banned today. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Below: Blacklisted's explanationWe organise and explain what the document says. The document above is the authority.
Key facts
- Chyawanprash
- Not banned; Dabur was the plaintiff when the Delhi High Court restrained Patanjali on 6 Nov 2025
- US FDA unapproved-drug alert (66-41)
- Dabur India: Hajmola and Fem bleach, 2024. Goods can be detained at the US border; not an Indian action
- India
- No ban, recall, failed-test row or licence action naming Dabur in the sources checked
- Honey
- No AYUSH action; food matters are on the food section
Dabur's ayurvedic products have no Indian AYUSH action against them in the sources we checked. Dabur Chyawanprash is not banned. On 6 Nov 2025 the Delhi High Court (Justice Tejas Karia), in Dabur India v Patanjali Ayurved, restrained Patanjali from calling all other chyawanprash 'dhoka'. Dabur was the plaintiff.
The US FDA's import alert 66-41 for unapproved drugs lists Dabur India for Hajmola and Fem bleach (2024). The alert allows the FDA to detain the goods at the US border. It is a US measure, not an Indian action, and it applies to the entries named, not to Dabur's other products.
What this means for you
The US entries are about the US market
An import alert lets the US FDA detain goods at its border. It applies to what is shipped to the US.
Chyawanprash
The only court order on record on Dabur Chyawanprash was won by Dabur and concerns a rival's advertising.
This is a record of official orders, not medical advice. Do not stop a prescribed medicine without asking your doctor or pharmacist.
Common questions
Is Dabur banned in any country?
No ban is on record. The only foreign entries we found are the 2024 US FDA unapproved-drug import-alert entries for Hajmola and Fem bleach.
Official sources and primary records
- US FDA Import Alert 66-41: unapproved drugsRegulatorUS Food and Drug Administration
- US FDA import alerts: entries for IndiaRegulatorUS Food and Drug Administration · 9 October 2026
- Del HC grants interim relief in Dabur v Patanjali chyawanprash caseNewsSCC Online · 12 November 2025
- Maharashtra FDA: not of standard quality (NSQ) alerts tableRegulatorMaharashtra Food and Drug Administration · 9 October 2026